Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
ONECUT1 | hg38_v1_chr15_-_52790324_52790352 | 0.76 | 3.9e-07 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_-_159714581 Show fit | 19.52 |
ENST00000255030.9
ENST00000437342.1 ENST00000368112.5 ENST00000368111.5 ENST00000368110.1 |
C-reactive protein |
|
chr1_+_56854764 Show fit | 18.04 |
ENST00000361249.4
|
complement C8 alpha chain |
|
chr17_-_28370283 Show fit | 17.84 |
ENST00000226218.9
|
vitronectin |
|
chr9_-_114078293 Show fit | 16.88 |
ENST00000265132.8
|
alpha-1-microglobulin/bikunin precursor |
|
chr1_+_159587817 Show fit | 16.82 |
ENST00000255040.3
|
amyloid P component, serum |
|
chr13_-_46105009 Show fit | 16.40 |
ENST00000439329.5
ENST00000674625.1 ENST00000181383.10 |
carboxypeptidase B2 |
|
chr12_+_111034136 Show fit | 14.90 |
ENST00000261726.11
|
cut like homeobox 2 |
|
chr3_-_171026709 Show fit | 13.57 |
ENST00000314251.8
|
solute carrier family 2 member 2 |
|
chr3_+_186666003 Show fit | 13.24 |
ENST00000232003.5
|
histidine rich glycoprotein |
|
chr3_+_52777580 Show fit | 13.14 |
ENST00000273283.7
|
inter-alpha-trypsin inhibitor heavy chain 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 25.6 | GO:0045959 | regulation of complement activation, classical pathway(GO:0030450) negative regulation of complement activation, classical pathway(GO:0045959) |
1.0 | 19.5 | GO:0032930 | positive regulation of superoxide anion generation(GO:0032930) |
4.7 | 18.7 | GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) |
1.0 | 18.0 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.9 | 17.8 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
1.3 | 16.9 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
5.6 | 16.8 | GO:1903015 | regulation of exo-alpha-sialidase activity(GO:1903015) |
4.1 | 16.4 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.6 | 14.9 | GO:0007614 | short-term memory(GO:0007614) |
2.7 | 13.6 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 59.2 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 35.9 | GO:0005615 | extracellular space(GO:0005615) |
0.2 | 25.6 | GO:0044215 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
1.1 | 23.8 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
2.3 | 18.7 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
2.0 | 18.0 | GO:0005579 | membrane attack complex(GO:0005579) |
5.9 | 17.8 | GO:0071062 | rough endoplasmic reticulum lumen(GO:0048237) alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.1 | 14.1 | GO:0005903 | brush border(GO:0005903) |
0.3 | 13.2 | GO:0036019 | endolysosome(GO:0036019) |
0.0 | 12.8 | GO:0000139 | Golgi membrane(GO:0000139) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.7 | 28.4 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
4.9 | 19.5 | GO:0033265 | choline binding(GO:0033265) |
0.6 | 18.0 | GO:0001848 | complement binding(GO:0001848) |
0.6 | 18.0 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
2.4 | 16.9 | GO:0019862 | IgA binding(GO:0019862) |
2.1 | 16.8 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.4 | 16.4 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 16.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
2.7 | 13.6 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.4 | 13.2 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 63.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.3 | 27.0 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.2 | 20.9 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.5 | 17.8 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.2 | 16.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 8.3 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 7.3 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 7.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 5.5 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 4.4 | PID ALK1 PATHWAY | ALK1 signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 43.6 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.9 | 22.2 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
1.4 | 19.5 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 15.8 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 14.9 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.5 | 14.0 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 11.8 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.4 | 11.4 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.3 | 11.0 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.3 | 9.0 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |